ESPE Abstracts (2023) 97 P2-279

ESPE2023 Poster Category 2 Late Breaking (77 abstracts)

The narrative of a patient with leptin receptor deficiency: personalized medicine for a rare genetic obesity disorder

Mila S. Welling 1,2 , Lotte Kleinendorst 3,4 , Mieke M. van Haelst 3,5 & Erica L.T. van den Akker 1,2


1Obesity Center CGG, Erasmus MC, University Medical Center, Rotterdam, Netherlands. 2Department of Pediatrics, Division of Endocrinology, Erasmus MC-Sophia Children's Hospital, University Medical Center, Rotterdam, Netherlands. 3Department of Human Genetics, Amsterdam Reproduction & Development Research Institute, Amsterdam UMC, Amsterdam, Netherlands. 4Emma Center for Personalized Medicine, Amsterdam UMC, Amsterdam, Netherlands. 5Emma Center for Personalized Medicine, Amsterdam UMC, Emma Center for Personalized Medicine, Amsterdam UMC, Netherlands


Leptin receptor deficiency is a rare genetic disorder that affects the body’s ability to regulate appetite and weight. For patients and their families, the disorder seriously disrupts daily life, however, little is published about this impact. We here report the experiences of a 10.5-year-old girl with leptin receptor deficiency and her family. The diagnosis of this rare genetic obesity had a deep impact on the life of the child and her family. It led to a better understanding of the cause of the impaired appetite regulation and early-onset obesity with subsequently less judgement by others and improved cooperation of their social network and school on maintaining a healthy lifestyle for this girl. A strict eating regimen and lifestyle measures resulted in the first year after diagnosis in a significantly decreased BMI, followed by BMI stabilization, still categorized as obesity class three. However, the troublesome challenge of how to manage the disruptive behaviour due to hyperphagia remained. Eventually, due to treatment with targeted pharmacotherapy, i.e., melanocortin-4 receptor agonists, her BMI continued to decrease due to resolving hyperphagia. The daily routine of the family and the atmosphere at home positively changed, as it was no longer dominated by the food-focused behaviour of the child and the adherence to the strict eating regimen. This case report demonstrates the importance and impact of a rare genetic obesity disorder diagnosis in a family. Additionally, it highlights the value of genetic testing in patients with a high suspicion of a genetic obesity disorder as it can eventually lead to personalized treatment, such as guidance by specialized healthcare professionals and educated caregivers or targeted pharmacotherapy.

Volume 97

61st Annual ESPE (ESPE 2023)

The Hague, Netherlands
21 Sep 2023 - 23 Sep 2023

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.